Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Lycium barbarum L polysaccharide ameliorates DSS-induced ulcerative colitis by improving gut barrier function and modulating gut microbiota

PROVIDER: PRJNA953837 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR24114234_1.fastq.gz	Fastqsanger.gz
	SRR24114234_2.fastq.gz	Fastqsanger.gz
	SRR24114235_1.fastq.gz	Fastqsanger.gz
	SRR24114235_2.fastq.gz	Fastqsanger.gz
	SRR24114236_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 80

Similar Datasets

Effect of Lycium barbarum polysaccharide-glycoprotein(LBP) on irradiated HaCaT cells

Project description:To investigate the protective effect of Lycium barbarum polysaccharide-glycoprotein (LBP) in the radiation-induced HaCaT cell injury, We performed gene expression profiling analysis using data obtained from RNA-seq of HaCaT cells at 3h after radiation.

2024-06-01 | GSE218507 | GEO

Anther transcriptome analysis of Lycium barbarum at different developmental stages

Project description:The causes of male sterility of Lycium barbarum were analyzed by comparing the anther transcriptomes of fertile and sterile lines

2025-07-23 | GSE236751 | GEO

Label-free quantitative data dependent (DDA) nano-LC-MS/MS analysis of proteomic changes in the mesenteric lymph harvested from healthy (control) and DSS-fed mice models of colitis

Project description:The gastrointestinal mucosa constitutes a critical barrier where millions of microbes and environmental antigens can interact with the host immune system. Intestinal barrier defects have been linked to a broad range of pathological states, including autoimmune, cancer and neurodegenerative diseases. Accordingly, it has been proposed as a leading therapeutic target. This research aimed to investigate the qualitative and quantitative changes in the proteomes of pre- and post-nodal mesenteric lymph at steady state and following inflammatory disruption of the intestinal barrier which could lead to the identification the antigenic and inflammatory load draining to the mesenteric lymph nodes, in both healthy and DSS-feed mice models of colitis and inflammatory bowel disease (IBD). To achieve this goal, we employed label-free quantitative (LFQ) bottom-up proteomics analysis of pre- and post-nodal mesenteric lymph. To map changes in the lymph composition following inflammatory damage, mice were fed dextran sulfate sodium (DSS), a sulfated polysaccharide which causes ulcerative colitis-like pathologies and as an additional inflammatory effect on the ileum mucosa. DSS-mediated inflammation in mice mediated significant qualitative and quantitative proteomic changes mapped to the release of damage-associated molecular pattern (DAMPS) in the afferent lymph, mostly generated from the damaged epithelia. In addition, molecular signatures of colitis/enteritis, organ injury and gastrointestinal inflammation were further found by the proteomics analysis. Importantly, enzymes normally confined to the gut, such as chymotrypsin, peptidases, phospholipases, elastases were mapped in the afferent lymph, consistent with the proteolysis and lipolysis observed following breaking down of the gut barrier.

2024-08-09 | PXD044885 | Pride

Project description:Lycium barbarum polysaccharide-glycoprotein ameliorates abnormal neural activity in depressive patient-derived ventral forebrain organoids

| PRJNA1206551 | ENA

Project description:Oryzanol Ameliorates DSS-Stimulated Gut Barrier Damage via Gut Microbiota

| PRJNA860540 | ENA

Lycium barbarum

Project description:Lycium barbarum

| PRJNA317623 | ENA

Project description:Lycium barbarum

| PRJNA445678 | ENA

Lycium-barbarum-root

Project description:Chemotyping dataset of n-butanol peptide extract of Lycium barbarum root

2018-06-29 | MSV000082527 | MassIVE

The study of precise nutrition intervention for colorectal cancer targeting intestinal flora

Project description:Interventions: experimental group 1:Lycium barbarum polysaccharides;Experimental group 2:probiotics;experimental group 3:probiotics+ Lycium barbarum polysaccharides;Control group:placebo Primary outcome(s): Short chain fatty acids;IL-1 beta;IL-6;IL-4;IL-10;Immune interferon;tumor necrosis factor;MUC-2;Bcl-xL;NF-kB;IkB alpha;CRP;SIgA;postoperative abdominal pain;Flora richness;Flora diversity;Flora structure Study Design: Parallel

| 2696263 | ecrin-mdr-crc

Project description:An acidic polysaccharide from Lycium barbarum L: Isolation, purification, structural characterization, and therapeutic effects of ulcerative colitis

| PRJNA1238823 | ENA

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data